Indications and uses
Helps prevent sunburn. Higher SPF provides more sunburn protection.
Urban Defense
- Manufacturer
- Urban Decay Cosmetics, LLC
- Effective date
- 2012-07-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:32:35
Label at a glance#
ProductUrban Defense
Active ingredientOctocrylene, Octinoxate
Label structure10 sections
Dosage and administration
Smooth liberally on face, neck and other exposed areas. Reapply if excess perspiration or product wear occurs.
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| Active Ingredient | Purpose |
|---|---|
| Octocrylene (8.0 %) | Sunscreen |
| Octinoxate (7.5%) | Sunscreen |
Uses
Helps prevent sunburn. Higher SPF provides more sunburn protection.
Warnings
For external use only
Keep out of eyes
- rinse with water to remove
OTC - STOP USE SECTION
Stop use and ask doctor if
- rash or irritation occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control center right away.
Directions
Smooth liberally on face, neck and other exposed areas. Reapply if excess perspiration or product wear occurs.
Inactive Ingredients
Aqua, Cetearyl Alcohol, Glyceryl Stearate, PEG-40 Castor Oil, Glycerin, Silica, Dimethicone, Dicaprylyl Carbonate, Ginkgo Biloba Leaf Extract, Chamomilla Recutita Flower Extract, Panax Ginseng Root Extract, Litchi Chinensis Pericarp Extract, Tocopheryl Acetate, Tetrahexyldecyl Ascorbate, Montmorillonite, Butylene Glycol, Xanthan Gum, Disodium EDTA, Caprylyl Glycol, Phenoxyethanol. All shades may contain (Toutes les couleurs peuvent contenir): CI77891, CI77491 / 77492 /77499 (Iron Oxides).
PRINCIPAL DISPLAY PANEL - 50 ml BODYGUARD Carton
ud
URBAN DECAY
URBAN DEFENSE
TINTED MOISTURIZER
PARABEN FREE
SPF 20
50 ml e 1.69 US OZ
PRINCIPAL DISPLAY PANEL - 50 ml BULLETPROOF Carton
ud
URBAN DECAY
URBAN DEFENSE
TINTED MOISTURIZER
PARABEN FREE
SPF 20
50 ml e 1.69 US OZ
PRINCIPAL DISPLAY PANEL - 50 ml FORCEFIELD Carton
ud
URBAN DECAY
URBAN DEFENSE
TINTED MOISTURIZER
PARABEN FREE
SPF 20
50 ml e 1.69 US OZ
PRINCIPAL DISPLAY PANEL - 50 ml HALO Carton
ud
URBAN DECAY
URBAN DEFENSE
TINTED MOISTURIZER
PARABEN FREE
SPF 20
50 ml e 1.69 US OZ
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a21a21e5-f36d-4c1f-8918-def921b8f7e3 | Product name | 3 | 20250124 |
| 6bd95106-a412-1dad-b9cc-4cb74bfb27ce | Product name | 2 | 20230315 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 290f523a-f9db-9774-b5a9-e1f908ac1782 | Product name | 1 | 20150828 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| c6b65c52-69c7-df49-550a-a50c137f6218 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51727-0631-1 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b975-f6ea-e053-dbdaa90aa703 | ud URBAN DECAY URBAN DEFENSE |
| 51727-0632-1 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b975-f6ea-e053-dbdaa90aa703 | ud URBAN DECAY URBAN DEFENSE |
| 51727-0633-1 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b975-f6ea-e053-dbdaa90aa703 | ud URBAN DECAY URBAN DEFENSE |
| 51727-0634-1 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b975-f6ea-e053-dbdaa90aa703 | ud URBAN DECAY URBAN DEFENSE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51727-0631-1 | Urban Defense | 50 mL in 1 TUBE | EMULSION | 50 | 1 | |
| 51727-0631-1 | Urban Defense | 1 in 1 CARTON | EMULSION | 1 | 1 | |
| 51727-0632-1 | Urban Defense | 1 in 1 CARTON | EMULSION | 1 | 1 | |
| 51727-0632-1 | Urban Defense | 50 mL in 1 TUBE | EMULSION | 50 | 1 | |
| 51727-0633-1 | Urban Defense | 50 mL in 1 TUBE | EMULSION | 50 | 1 | |
| 51727-0633-1 | Urban Defense | 1 in 1 CARTON | EMULSION | 1 | 1 | |
| 51727-0634-1 | Urban Defense | 50 mL in 1 TUBE | EMULSION | 50 | 1 | |
| 51727-0634-1 | Urban Defense | 1 in 1 CARTON | EMULSION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51727-0631 | URBAN DEFENSE (OCTOCRYLENE AND OCTINOXATE) EMULSION [URBAN DECAY COSMETICS, LLC] | 1 | Legacy NDC, 2 package rows | 20120716_a9e0c9ed-fb28-468c-b15b-a33f553bf628.zip |
| 51727-0632 | URBAN DEFENSE (OCTOCRYLENE AND OCTINOXATE) EMULSION [URBAN DECAY COSMETICS, LLC] | 1 | Legacy NDC, 2 package rows | 20120716_a9e0c9ed-fb28-468c-b15b-a33f553bf628.zip |
| 51727-0633 | URBAN DEFENSE (OCTOCRYLENE AND OCTINOXATE) EMULSION [URBAN DECAY COSMETICS, LLC] | 1 | Legacy NDC, 2 package rows | 20120716_a9e0c9ed-fb28-468c-b15b-a33f553bf628.zip |
| 51727-0634 | URBAN DEFENSE (OCTOCRYLENE AND OCTINOXATE) EMULSION [URBAN DECAY COSMETICS, LLC] | 1 | Legacy NDC, 2 package rows | 20120716_a9e0c9ed-fb28-468c-b15b-a33f553bf628.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| Octocrylene | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| Octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| Octocrylene | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| ACETATE ION | INACTIVE INGREDIENT | 569DQM74SC | 1 | |
| ASIAN GINSENG | INACTIVE INGREDIENT | CUQ3A77YXI | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| DICAPRYLYL CARBONATE | INACTIVE INGREDIENT | 609A3V1SUA | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| GINKGO | INACTIVE INGREDIENT | 19FUJ2C58T | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| LITCHI FRUIT | INACTIVE INGREDIENT | Y5P61KP51E | 1 | |
| MATRICARIA RECUTITA | INACTIVE INGREDIENT | G0R4UBI2ZZ | 1 | |
| MONTMORILLONITE | INACTIVE INGREDIENT | A585MN1H2L | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POLYOXYL 40 CASTOR OIL | INACTIVE INGREDIENT | 4ERD2076EF | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| TETRAHEXYLDECYL ASCORBATE | INACTIVE INGREDIENT | 9LBV3F07AZ | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- Urban Defense
- Octocrylene and Octinoxate
- Octocrylene
- Octinoxate
- WATER
- CETOSTEARYL ALCOHOL
- GLYCERYL MONOSTEARATE
- POLYOXYL 40 CASTOR OIL
- GLYCERIN
- SILICON DIOXIDE
- DIMETHICONE
- DICAPRYLYL CARBONATE
- GINKGO
- MATRICARIA RECUTITA
- ASIAN GINSENG
- LITCHI FRUIT
- ACETATE ION
- TETRAHEXYLDECYL ASCORBATE
- MONTMORILLONITE
- BUTYLENE GLYCOL
- XANTHAN GUM
- EDETATE DISODIUM
- CAPRYLYL GLYCOL
- PHENOXYETHANOL
- TITANIUM DIOXIDE
- FERRIC OXIDE RED
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 51727-0631 | 51727-0631-1 |
| 51727-0632 | 51727-0632-1 |
| 51727-0633 | 51727-0633-1 |
| 51727-0634 | 51727-0634-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 6 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED / ORAL | 3 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | SUPPOSITORY / VAGINAL | NA | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / INTRA-ARTICULAR | 1 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 69 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, CHEWABLE / ORAL | 2 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / TOPICAL | 0.11 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVASCULAR | 0.48 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / TOPICAL | 126 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / AURICULAR (OTIC) | 0.1 %w/v | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | AEROSOL, FOAM / TOPICAL | 3.27 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, DELAYED RELEASE / ORAL | 6 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / OPHTHALMIC | 0.06 %w/v | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SYSTEM / TOPICAL | 420 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SUSPENSION / ORAL | 113 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 42 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 2 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / VAGINAL | 3 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | EMULSION / TOPICAL | 0.11 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / SUBLINGUAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 11 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SOFT TISSUE | 0.05 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SPRAY / RESPIRATORY (INHALATION) | 0.05 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, EMULSION / INTRAVENOUS | 59 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / ORAL | 2 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | 168 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / TOPICAL | 836 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / NASAL | 0.1 mg/1ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, CHEWABLE / ORAL | 1 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, EXTENDED RELEASE / TRANSDERMAL | 49 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, SOLUBLE / ORAL | 2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.4 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LIQUID / TOPICAL | 1 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | DROPS / ORAL | NA | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, DELAYED RELEASE / ORAL | 37 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, FILM COATED / ORAL | 4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO, SUSPENSION / TOPICAL | 1 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE, DENTIFRICE / DENTAL | 0.4 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | POWDER, FOR SUSPENSION / ORAL | 285 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRA-ARTICULAR | 0.05 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED / ORAL | 17 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 92c06df6-f2e8-458a-b19f-5dd28daa52e4 | a9e0c9ed-fb28-468c-b15b-a33f553bf628 | 2012-07-02 | Warnings | 92c06df6-f2e8-458a-b19f-5dd28daa52e4 a9e0c9ed-fb28-468c-b15b-a33f553bf628 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.